Trial Profile
A retrospective observational trial of infliximab and adalimumab in pediatric patients with Crohn disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 02 Dec 2015 New trial record